20 countries win zero tariff on specialty pharma; 100% hits others Sept 29
The US waives ad valorem tariffs on specialty drugs and components from 20 countries, including India, while a 100% tariff on patented pharma imports takes effect September 29. Supply chain teams must re-evaluate sourcing, country-of-origin classification, and customs exposure for rare disease, cell/gene, and ADC products.